Delivering antiviral siRNA into human T-cells: New approaches in RNAi-based HIV therapy
- Authors
- Ban, Hong-Seok; Lee, Sang-Kyung; Kumar, Priti
- Issue Date
- Dec-2009
- Publisher
- THOMSON REUTERS (SCIENTIFIC) LTD
- Keywords
- HIV; RNAi; siRNA; targeted delivery; T-cell
- Citation
- IDRUGS, v.12, no.12, pp.774 - 778
- Indexed
- SCIE
SCOPUS
- Journal Title
- IDRUGS
- Volume
- 12
- Number
- 12
- Start Page
- 774
- End Page
- 778
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/175778
- ISSN
- 1369-7056
- Abstract
- The ability to block the expression of any disease-causing gene or disease-related protein highlights the potential use of RNAi technology in the therapy of 'undruggable' human diseases. However, considering the risks associated with RNAi therapy, targeting and restricting the action of siRNA to specific cells could greatly minimize toxic side effects. However, this is a major challenge, as many primary cell types are highly recalcitrant to siRNA uptake. This review discusses advances in siRNA targeting methods for human T-cells, with an emphasis on the potential use of an RNAi-based therapy for the treatment of HIV/AIDS.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 공과대학 > 서울 생명공학과 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.